All
Supplements May Lead to Financial, Adherence Issues in Breast Cancer
November 11th 2023Up to a quarter of patients with breast cancer face financial burden due to the cost of supplements, complimentary therapy and alternative medicines which “may decrease adherence to prescribed medications,” researchers found.
Patrick Dempsey Reflects on His Nonprofit, ‘General Hospital’ Star Talks Cancer and More
November 10th 2023From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.
FDA Approves Fruzaqla for Previously Treated Metastatic Colorectal Cancer
November 9th 2023Patients with metastatic colorectal cancer are eligible for treatment with Fruzaqla, an oral targeted therapy, following treatment via fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy as well as an anti-VEGF therapy, and, if their disease RAS wild-type and medically appropriate, an anti-EGFR therapy.